<DOC>
	<DOCNO>NCT02399449</DOCNO>
	<brief_summary>An approved treatment anemia low blood count due chronic kidney disease IV ( intravenous , give vein ) injection iron treatment . IV iron increase iron blood . Many IV iron therapy available brand name generic form . One common IV iron product sodium ferric gluconate ( SFG ) sell brand name Ferrlecit . Recently , generic version Ferrlecit approve felt possibly toxic brand product . The purpose research project see brand generic IV iron product produce amount iron blood healthy volunteer , include iron form toxic iron form .</brief_summary>
	<brief_title>IV Iron Safety : Evaluation Iron Species Healthy Subjects</brief_title>
	<detailed_description>A generic version Ferrlecit approve 2011 available . Shortly approval generic , 'Reflections Paper Non-Clinical Studies Generic Nanoparticle Iron Medicinal Product Applications ' publish European Medicines Agency . The author paper propose generic iron preparation deliver increase level 'labile iron ' plasma result oxidative damage toxicity . As , study measure vivo level free labile iron generic versus brand iron-preparations recommend . The primary outcome assessment non-inferiority generic colloid product reference colloid product respect non-transferrin bound iron ( NTBI ) , single-dose i.v . administration brand generic sodium ferric gluconate injection n=48 healthy subject .</detailed_description>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric gluconate</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>View 1 Males female , age 1865 year old , systolic blood pressure within 90150 , diastolic blood pressure within 6090 View 2 Healthy volunteer : Subjects good health include iron replete anemic , determine screen evaluation great 30 day first drug study visit View 3 Willing avoid caffeine containing product 24 hour prior day study visit View 4 Willing stop OTC medication 24 hour prior study visit View 5 Able provide inform consent View 1 Presence significant medical disease ( include cardiovascular , pulmonary , hematologic , endocrine , immunologic , neurologic , gastrointestinal psychiatric ) View 2 Subjects iron deficient iron overload View 3 Presence hepatic renal disease View 4 Pregnant woman , breast feeding try become pregnant View 5 Excessive alcohol use ( i.e . current physical , behavioral , personal manifestation relate abuse dependency alcohol ) View 6 Routine use ( i.e . daily weekly ) prescription medication except birth control pills View 7 Currently take iron form ( e.g . oral IV ) View 8 Allergic IV iron , include sodium ferric gluconate , inactive component , include benzyl alcohol View 9 Undergoing therapy solid tumor blood malignancy View 10 Any condition opinion PI medical physician would increase risk subject interfere integrity study View 11 Donated blood within last 56 day screen . Received IV iron RBC transfusion ( ) 10 day prior screen . Plan donate blood , receive IV iron RBC transfusion ( ) , study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>iron</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>